Loading...
Hydroxychloroquine and COVID-19: can we learn from the use of rituximab in systemic lupus erythematosus?
Rituximab (RTX), a chimeric monoclonal anti-CD20 antibody has become part of the standard therapy for patients with CD20-expressing B-cell lymphoma and rheumatoid arthritis. After encouraging results with open studies in systemic lupus erythematosus (SLE), RTX has not shown its effectiveness in rand...
Na minha lista:
| Udgivet i: | Pan Afr Med J |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The African Field Epidemiology Network
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8308936/ https://ncbi.nlm.nih.gov/pubmed/34367451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11604/pamj.2021.38.372.29087 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|